Search Results 271-280 of 85403 for Active

  1. Rabies vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

    Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own ...

  2. Tofacitinib (oral route) - Side effects & dosage - Mayo Clinic

    Tofacitinib is used alone or together with other medicines (eg, DMARDs) to treat moderate to severely active rheumatoid arthritis, active psoriatic ...

  3. Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome - Mayo Clinic

    The primary objective of this study is to assess the efficacy of filgotinib, GS-9876, and tirabrutinib (formerly GS-4059) in adults with active Sjogren's ...

  4. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001). Print ...

  5. Uveitis Clinical Trials - Mayo Clinic Research

    ... Active, Non-Infectious Uveitis of the Posterior Segment of the Eye Jacksonville, FL. The purpose of this study is to assess the effectiveness and safety of ...

  6. Arthritis pain: Treatments absorbed through your skin - Mayo Clinic

    After an active weekend of hiking or working around the yard, your joints might continue to hurt even after taking arthritis pain medicine. Don't want to ...

  7. Infant development: Milestones from 7 to 9 months - Mayo Clinic

    Milestones for most 7- to 9-month-old infants include improved motor and language skills.

  8. Rheumatoid arthritis - Symptoms and causes - Mayo Clinic

    Periods when the condition becomes more active, called flares, follow periods of less or no swelling and pain. This is called remission. Over time ...

  9. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Moderate-to-Severe, Active Crohn's Disease - Mayo Clinic

    ... active Crohn's disease into clinical remission at Week 1-8 compared with the ... active Crohn's disease randomized to ustekinumab in the CNTO1275CRD3001 and ...

  10. Infliximab-dyyb (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    ... active rheumatoid arthritis. Infliximab-dyyb injection is also used to reduce the symptoms and prevent the progression of active ankylosing spondylitis. It ...